The University of Hawaii (UH) is seriously concerned for any researcher, staff member, and support personnel working on material with SARS-COV2. As guidance for working with COVID-19 material, please direct your attention to and practice these safety guidelines from the CDC, NIH, and ABSA.
The Biological Safety Program (BSP) ensures the protection of faculty, support staff, students by providing training and advisement through best practices; the general public, and Hawaii’s natural environment from the exposure to deleterious agents that are biological (including Select Agents and toxins), microorganisms, and recombinant genetic biomaterials which may be considered infectious and transmitted through various means of dispersal.
In addition, the BSP administers the Institutional Biosafety Committee (IBC). The IBC is responsible for ensuring that research, testing, and instruction on biological materials that involve potentially infectious agents and recombinant genetic biomaterials are assessed by regular registration reviews and on-site monitoring of laboratory and field activities of new and ongoing use.
In collaboration with the Environmental Health and Safety Office (ESHO) and various campus health specialists and their departmental officials, the BSP ensures that biomaterial activities have registered inventory declarations, permitting, and on-site monitoring of laboratory and field activities of new and ongoing biomaterial use.
UH Biosafety Program and IBC Registered: NIH Office of Biotechnology Activities/Office of Scientific Policy
Expiration date: September 2022